Viewing Study NCT00826969


Ignite Creation Date: 2025-12-24 @ 11:04 PM
Ignite Modification Date: 2026-04-23 @ 5:34 PM
Study NCT ID: NCT00826969
Status: COMPLETED
Last Update Posted: 2016-12-02
First Post: 2009-01-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Ciclesonide for the Treatment of Airway Hyperresponsiveness
Sponsor: AstraZeneca
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: BY9010/CH-101
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators